Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice
about
Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsMitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approachesMitochondrial genome changes and neurodegenerative diseasesThymidine Phosphorylase Participates in Platelet Signaling and Promotes ThrombosisA novel structural mechanism for redox regulation of uridine phosphorylase 2 activityNucleotide salvage deficiencies, DNA damage and neurodegenerationClinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathyLimited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiencyThiamine Deficiency-Mediated Brain Mitochondrial Pathology in Alaskan Huskies with Mutation in SLC19A3.1.Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency.Therapeutic prospects for mitochondrial disease.The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy.Reciprocal regulation of autophagy and dNTP pools in human cancer cells.Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice.Modeling pathogenic mutations of human twinkle in Drosophila suggests an apoptosis role in response to mitochondrial defects.Long term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances.Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesisMetabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondriaAllogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancerA discovery resource of rare copy number variations in individuals with autism spectrum disorder.Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.Two transgenic mouse models for β-subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterationsIncreased deoxythymidine triphosphate levels is a feature of relative cognitive decline.Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion.Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy.Pathogenesis and treatment of mitochondrial myopathies: recent advances.Mitochondrial dysfunction in central nervous system white matter disorders.Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy.Mitochondrial purine and pyrimidine metabolism and beyond.Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE.Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.
P2860
Q26795417-899C65A9-D013-4373-8255-3F9B5F6D8492Q26801561-687BF164-3EEF-41B3-ACF2-47C81F3CEEE6Q27023750-504193F2-C6F1-459A-8FD3-DF561DE90F01Q27339642-713375BA-BBDE-4F1A-9262-0A94A7890787Q27671841-CF4F8BDC-5E3A-4932-A289-500BADE43050Q28081515-9F283D4F-CE2E-4656-B746-9B5239BDAFD3Q28248577-DA1CADA2-2DAB-4DAF-B7B6-0A1AB236F373Q28477625-4D7390AE-4CEC-4DB1-9913-9C4CCC8AC3A8Q28588893-A8A6C64A-2BC4-47DB-9085-6E4AB308B9ADQ30365632-D86B4439-8502-4FEE-92D4-DC5FBA6F4693Q34131169-E0C2FCB4-8164-4C3C-B5BB-7EA782A44B47Q34205124-37A9ED64-D144-4B6D-8A72-FCD30E5D2905Q34369558-D0EA1FD1-2379-4469-A508-73A2219E9EE0Q34373116-12E42480-48B0-4040-AD2C-66FCADF323FAQ34401495-21FCEBEF-84EC-47FA-9284-E4CA53FA4832Q34405895-B66BFEEC-D66F-457F-A489-A7D618467C84Q34552728-3D6E8D08-B0DB-4E3E-8CB4-D6F3438AF87EQ34768395-07ECC882-1565-403C-ADDC-ABBD8BFDE9DBQ35660977-FCCFF7E3-5550-48B2-98E3-F7C55DDB9E79Q35870630-7632F744-0B56-47F9-BE1D-31DB73BFB15EQ35893619-16458A26-E22B-4F1C-8113-891CD7C7F5F5Q35941463-EE80C3B8-35B6-4251-BCF5-994CF5A1F1ECQ36060187-D7C1A993-5CEC-4E3C-8BE5-C99A903CC427Q36082784-8B26AE71-53CB-4C62-A6A8-0B76B8AEBD05Q36351040-EDEC6567-229F-415F-AD9F-791694057861Q36394649-41E26C31-0EB0-40BF-A265-508A0B550601Q36451331-53B6525B-BA9A-4B8C-8584-2B98BECE4742Q36517059-5492D3A3-49C8-40BA-8108-56AB9D2D55FDQ37132309-B9555F4F-327F-4EC0-ACD3-2A254E7457ADQ37449919-54662F18-8F6B-4D3D-BBD4-0C632FC49227Q37524841-BC277957-197F-40DC-A5DE-761E2C451918Q37566132-D1D6678E-2035-4A28-AE9C-36445BE7E1DBQ37723433-54C9F919-935A-43F3-B0A3-3AF4FFA671A8Q37840050-E89F61D3-0B6E-47BB-9535-DB1DC1594300Q38215315-B5FCA9C4-C281-491D-8E68-414800916392Q38750535-30C497E2-BDCB-4B1A-AB64-9CDE5FAB4083Q38997243-B4AD78F7-AE40-4A20-95EC-0DBF9C3A6E09Q39025697-22BE795E-193E-4916-9503-50C73FF608D6Q39413079-A6D3BD4D-760B-4280-9025-DC02706E8ECDQ39568001-185EAF55-36FC-46E6-9C25-B20A901E743A
P2860
Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Unbalanced deoxynucleotide poo ...... e phosphorylase-deficient mice
@en
Unbalanced deoxynucleotide poo ...... phosphorylase-deficient mice.
@nl
type
label
Unbalanced deoxynucleotide poo ...... e phosphorylase-deficient mice
@en
Unbalanced deoxynucleotide poo ...... phosphorylase-deficient mice.
@nl
prefLabel
Unbalanced deoxynucleotide poo ...... e phosphorylase-deficient mice
@en
Unbalanced deoxynucleotide poo ...... phosphorylase-deficient mice.
@nl
P2093
P2860
P356
P1476
Unbalanced deoxynucleotide poo ...... e phosphorylase-deficient mice
@en
P2093
Angeles García-Cazorla
Beatriz Dorado
Dikoma Shungu
Eduardo Bonilla
Giuseppe Pizzorno
Hasan O Akman
Ichizo Nishino
Kurenai Tanji
Luis C López
Michio Hirano
P2860
P304
P356
10.1093/HMG/DDN401
P577
2008-11-21T00:00:00Z